Home / Companies / Akebia Therapeutics, Inc. / 10 Jun 2025
Akebia Therapeutics, Inc.: meeting of 10 Jun 2025
Votes reported on Form N-PX, item by item
184 Form N-PX filers reported votes at the Akebia Therapeutics, Inc. meeting of 10 Jun 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 75.6% of reported votes for; 36 filers withheld from or voted against at least one nominee.
244 vote records from 67 filers. 3 of the 65 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
262 vote records from 182 filers. 14 of the 175 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
122 vote records from 67 filers. 2 of the 65 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
124 vote records from 69 filers. 3 of the 67 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | Abstain or withhold * | For | For |
| State Street and SPDR | For | For | For |
| American Century | No report | Against * | No report |
| Franklin Templeton | For | For | For |
| Invesco | Split or no vote | Against * | For |
| Equitable | For | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | For | For | For |
| ProShares and ProFunds | Split or no vote | For | For |
| John Hancock and Manulife | Split or no vote | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | Against * | For |
| J.P. Morgan | No report | For | No report |
| Goldman Sachs | Split or no vote | For | For |
| PGIM and Prudential | No report | For | No report |
| Jackson National funds | Abstain or withhold * | For | For |
| Northern Trust and FlexShares | Split or no vote | For | For |
| SEI | For | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | Split or no vote | For | For |
| Voya | Split or no vote | For | For |
| Russell Investments | Split or no vote | For | Split or no vote |
| Nationwide | For | For | For |
| Victory Capital | Split or no vote | For | For |
| Brighthouse Funds | Split or no vote | For | For |
| Guggenheim and Rydex | Split or no vote | For | For |
| Columbia Threadneedle | Split or no vote | For | For |
| BNY Mellon | No report | For | No report |
| Principal | No report | For | No report |
| Pacific Life funds | For | For | For |
| Global X | For | For | For |
| Federated Hermes | For | For | For |
| AllianceBernstein | No report | For | No report |
| DWS | Split or no vote | For | For |
| Neuberger Berman | No report | For | No report |
| Baird | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Akebia Therapeutics, Inc. meeting?
184 Form N-PX filers reported votes at the meeting of 10 Jun 2025. On say-on-pay, 14 of 175 voted against management (8.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Akebia Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Akebia Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Akebia Therapeutics, Inc. with a meeting date within three days of 10 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.